We have located links that may give you full text access.
Journal Article
Review
Anti-toxoplasmosis drugs.
Current Opinion in Investigational Drugs 2001 October
The drugs most commonly used for treatment of toxoplasmosis combine folate inhibitors that frequently cause undesirable side effects. There is an urgent need for new drugs or drug combinations that are able to eradicate the tissue cysts responsible for relapses, particularly for patients intolerant to folate inhibitors. Although promising for its activity against cysts, atovaquone is still limited by its variable intestinal absorption. The recent demonstration that the apicoplast of Toxoplasma gondii could be a possible unique drug target for antibiotics such as macrolides and fluoroquinolones represented an important breakthrough in this area.
Full text links
Related Resources
Trending Papers
Executive Summary: State-of-the-Art Review: Unintended Consequences: Risk of Opportunistic Infections Associated with Long-term Glucocorticoid Therapies in Adults.Clinical Infectious Diseases 2024 April 11
Autoimmune Hemolytic Anemias: Classifications, Pathophysiology, Diagnoses and Management.International Journal of Molecular Sciences 2024 April 13
Clinical practice guidelines on the management of status epilepticus in adults: A systematic review.Epilepsia 2024 April 13
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app